Teladoc,Inc. (NYSE:TDOC) Files An 8-K Regulation FD Disclosure


Teladoc,Inc. (NYSE:TDOC) Files An 8-K Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure.

On January9, 2017, Teladoc,Inc. (Teladoc) issued a press release
announcing preliminary 2016 financial results and preliminary
guidance related to its 2017 outlook. A copy of the press release
is furnished hereto as Exhibit99.1.

On January9, 2017, Teladoc will present at the 35th Annual J.P.
Morgan Healthcare Conference in San Francisco, California,
beginning at 8:30 AM Pacific Time. A copy of the presentation
materials is furnished hereto as Exhibit99.2. There will be a
live audio webcast of the event accessible via Teladocs Investor
Relations website.

The information contained herein and in the accompanying exhibits
shall not be deemed filed for the purposes of Section18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liability of that section, nor shall
it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such a

Item 9.01. Financial Statements and Exhibits.


Exhibit No.



Teladoc,Inc. press release, dated January9, 2017


Teladoc,Inc. slide presentation, dated January9, 2017

About Teladoc, Inc. (NYSE:TDOC)

Teladoc, Inc., together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Its enterprise scale platform is offered for real-time sharing of clinical and non-clinical data in real time among the Teladoc constituents, which include Members, Providers, physician network operations center staff, nurses, SureScripts for electronic medication prescription writing, routing and fulfillment and health plans for claims processing, clinical summaries and clinical alerts.

Teladoc, Inc. (NYSE:TDOC) Recent Trading Information

Teladoc, Inc. (NYSE:TDOC) closed its last trading session up +0.90 at 17.45 with 749,679 shares trading hands.